Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Citicoline: pharmacological and clinical review, 2010 update.

Secades JJ.

Rev Neurol. 2011 Mar 14;52 Suppl 2:S1-S62. Review. English, Spanish.

2.

Citicoline: pharmacological and clinical review, 2016 update.

Secades JJ.

Rev Neurol. 2016 Dec 23;63(S03):S1-S73. Review. Spanish, English.

PMID:
28417449
3.

Citicoline: pharmacological and clinical review, 2006 update.

Secades JJ, Lorenzo JL.

Methods Find Exp Clin Pharmacol. 2006 Sep;28 Suppl B:1-56. Review.

PMID:
17171187
4.
5.

Neuroprotective properties of citicoline: facts, doubts and unresolved issues.

Grieb P.

CNS Drugs. 2014 Mar;28(3):185-93. doi: 10.1007/s40263-014-0144-8. Review.

6.

CDP-choline: pharmacological and clinical review.

Secades JJ, Frontera G.

Methods Find Exp Clin Pharmacol. 1995 Oct;17 Suppl B:1-54. Review.

PMID:
8709678
7.
8.

Citicoline. Monograph.

[No authors listed]

Altern Med Rev. 2008 Mar;13(1):50-7. No abstract available.

9.

Citicoline (Cognizin) in the treatment of cognitive impairment.

Fioravanti M, Buckley AE.

Clin Interv Aging. 2006;1(3):247-51. Review.

10.

Citicoline (CDP-choline): mechanisms of action and effects in ischemic brain injury.

D'Orlando KJ, Sandage BW Jr.

Neurol Res. 1995 Aug;17(4):281-4. Review.

PMID:
7477743
11.

Efficacy of citicoline as an acute stroke treatment.

Clark WM.

Expert Opin Pharmacother. 2009 Apr;10(5):839-46. doi: 10.1517/17460440902835475 .

PMID:
19351232
12.

Citicoline for traumatic brain injury: report of two cases, including my own.

Spiers PA, Hochanadel G.

J Int Neuropsychol Soc. 1999 Mar;5(3):260-4.

PMID:
10217926
13.

[The current state of citicholine in cerebral ischemia].

Abad-Santos F, Gallego-Sandín S, Novalbos J, Gálvez-Múgica MA.

Rev Neurol. 2000 Apr 1-15;30(7):663-70. Review. Spanish.

PMID:
10859748
14.

A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group.

Clark WM, Warach SJ, Pettigrew LC, Gammans RE, Sabounjian LA.

Neurology. 1997 Sep;49(3):671-8.

PMID:
9305321
15.

Citicoline, use in cognitive decline: vascular and degenerative.

García-Cobos R, Frank-García A, Gutiérrez-Fernández M, Díez-Tejedor E.

J Neurol Sci. 2010 Dec 15;299(1-2):188-92. doi: 10.1016/j.jns.2010.08.027. Epub 2010 Sep 27. Review.

PMID:
20875651
16.

Citicoline. Ferrer Internacional.

Alexandrov AV.

Curr Opin Investig Drugs. 2001 Dec;2(12):1757-62. Review.

PMID:
11892942
17.

[Treatment of mild cognitive impairment: value of citicoline].

Abad-Santos F, Novalbos-Reina J, Gallego-Sandín S, García AG.

Rev Neurol. 2002 Oct 1-15;35(7):675-82. Review. Spanish.

18.

[Agentss to improve cerebrovascular circulation and cerebral metabolism--citicoline].

Miyazaki M.

Nihon Rinsho. 1985 Feb;43(2):372-5. Japanese. No abstract available.

PMID:
3999407
19.

Citicoline preclinical and clinical update 2009-2010.

Dávalos A, Secades J.

Stroke. 2011 Jan;42(1 Suppl):S36-9. doi: 10.1161/STROKEAHA.110.605568. Epub 2010 Dec 16. Review.

20.

Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators.

Warach S, Pettigrew LC, Dashe JF, Pullicino P, Lefkowitz DM, Sabounjian L, Harnett K, Schwiderski U, Gammans R.

Ann Neurol. 2000 Nov;48(5):713-22.

PMID:
11079534

Supplemental Content

Support Center